UBS Group’s B.A.D. ETF BAD Stock Holding History

UBS Group’s Portfolio BAD Stock Details BAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-1,939	Closed	-$23.7K	–	10400
2023 Q3	$23.7K	Buy	1,939 +1,535	+380%	+$19.9K	﹤0.01%	6715
2023 Q2	$5.16K	Buy	404 +118	+41%	+$1.51K	﹤0.01%	7468
2023 Q1	$3.71K	Sell	286 -190	-40%	-$2.44K	﹤0.01%	8286
2022 Q4	$5.93K	Sell	476 -848	-64%	-$10.6K	﹤0.01%	9109
2022 Q3	$15K	Buy	1,324 +1,107	+510%	+$13.5K	﹤0.01%	7857
2022 Q2	$3K	Buy	+217	New	+$2.8K	﹤0.01%	9423
2022 Q1	–	Sell	-325	Closed	-$5K	–	11201
2021 Q4	$5K	Buy	+325	New	+$4.92K	﹤0.01%	9445

UBS Group's BAD Position: Q4 2023 in Review

UBS Group sold out of B.A.D. ETF (BAD) in Q4 2023, closing a stake of 1,939 shares — an estimated $23.7K sold.

UBS Group first reported a position in BAD in Q4 2021 and held it in 7 quarters. The position peaked at $23.7K in Q3 2023. 0 funds tracked by Wall St. Rank hold BAD as of Q4 2023.

UBS Group reported no remaining B.A.D. ETF position as of Q4 2023 after selling out during the quarter.
UBS Group sold 1,939 B.A.D. ETF shares in Q4 2023, an estimated $23.7K.
UBS Group first reported a position in B.A.D. ETF in Q4 2021 and held it in 7 quarters.
UBS Group's B.A.D. ETF position peaked at $23.7K in Q3 2023.
0 funds tracked by Wall St. Rank held B.A.D. ETF as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.